Cargando…
Effect of β‐Blockers Beyond 3 Years After Acute Myocardial Infarction
BACKGROUND: The optimal duration of β‐blocker therapy in patients with acute myocardial infarction (AMI) is unknown. We aimed to evaluate the late effect of β‐blockers in patients with AMI. METHODS AND RESULTS: We enrolled all consecutive patients who presented with AMI at Seoul National University...
Autores principales: | Park, Jin Joo, Kim, Sun‐Hwa, Kang, Si‐Hyuck, Yoon, Chang‐Hwan, Cho, Young‐Seok, Youn, Tae‐Jin, Chae, In‐Ho, Choi, Dong‐Ju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5866322/ https://www.ncbi.nlm.nih.gov/pubmed/29502101 http://dx.doi.org/10.1161/JAHA.117.007567 |
Ejemplares similares
-
New-onset paroxysmal atrial fibrillation in acute myocardial infarction: increased risk of stroke
por: Lee, Ji Hyun, et al.
Publicado: (2020) -
Impact of statin intensity on adverse cardiac and cerebrovascular events in older adult patients with myocardial infarction
por: Moon, In Tae, et al.
Publicado: (2021) -
Surveillance of Arrhythmia in Patients After Myocardial Infarction Using Wearable Electrocardiogram Patch Devices: Prospective Cohort Study
por: Kwun, Ju-Seung, et al.
Publicado: (2022) -
Evaluation of Heart-type Fatty Acid-binding Protein in Early Diagnosis of Acute Myocardial Infarction
por: Moon, Mi-Gil, et al.
Publicado: (2021) -
Differential Prognostic Impacts of Diabetes over Time Course after Acute Myocardial Infarction
por: Kim, Hack-Lyoung, et al.
Publicado: (2013)